TradingKey Balance sheet
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 3607
- Sources here
- 17
- Companies here
- 23
Active search
3607 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of "Moderate Buy" by Brokerages
Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus "Moderate Buy" rating from 14 analysts, with seven rating it a "buy" and seven a "hold." The average 12-month price target is $29.92, surpassing its current share price of $23.94, despite some recent analyst downgrades …
AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen has downgraded AdaptHealth (NASDAQ:AHCO) from a "hold" to a "sell" rating, despite the broader consensus of "Moderate Buy" among analysts with an average price target of $10.29. The company's shares opened at $5.81, near their 52-week low, and below their 50-day …
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
Edelson Lechtzin LLP, a national class action law firm, is investigating a data breach at AdaptHealth Corp. that exposed patient data. The breach, disclosed on July 2, 2026, involved a social engineering attack that compromised a third-party contractor's credentials, leading to unauthorized access to …
Optimum Communications (NYSE:OPTU) Stock Gets Fair Value Trim As Analysts Split On Risk
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The latest update for Optimum Communications focuses on a reduced fair value estimate, shifting …
Corcept therapeutics chief development officer sells $1.8m in stock
William Guyer, Chief Development Officer at Corcept Therapeutics Inc. (NASDAQ:CORT), sold shares worth approximately $1.85 million on August 10, 2026, through two separate transactions under a 10b5-1 plan. Despite the sales, which occurred while the stock was near its 52-week high, Guyer also acquired …
PTC Therapeutics Is Maintained at Overweight by Barclays
Barclays has reiterated its 'Overweight' rating on PTC Therapeutics (PTCT). The analyst firm maintained a price target of $70.00 for the company's stock. This indicates a positive outlook from Barclays regarding PTC Therapeutics' future performance.
Neptune Insurance CFO James Steiner Sells 100,000 Shares Over Two Days in August 2026
James Steiner, CFO and Director of Neptune Insurance Holdings Inc. (NP), sold a total of 100,000 shares of Class A Common Stock over two days in August 2026. The sales occurred on August 12 and 13, at weighted average prices of $31.0755 and $31.7121 …
Walleye Capital LLC Takes $1.59 Million Position in PTC Therapeutics, Inc. $PTCT
Walleye Capital LLC has acquired a new position in PTC Therapeutics, Inc., purchasing 19,522 shares valued at approximately $1.59 million during the second quarter. Several other institutional investors also increased their holdings in the biopharmaceutical company, which has an average analyst rating of "Moderate …
PTC Inc. $PTC Shares Purchased by Meyer Handelman Co.
Meyer Handelman Co. significantly increased its stake in PTC Inc. (NASDAQ:PTC) during the second quarter, purchasing an additional 44,340 shares to bring its total holdings to 92,884 shares valued at $10.55 million. This purchase reflects continued institutional interest, as institutional investors and hedge funds …
Dimensional Fund Advisors LP Sells 100,721 Shares of Optical Cable Corporation $OCC
Dimensional Fund Advisors LP reduced its stake in Optical Cable Corporation (NASDAQ:OCC) by 37.5%, selling over 100,000 shares but still retaining a significant holding. This comes as the company's CFO also sold a portion of her shares. Despite a recent 7.0% stock price increase, …
Cornerstone Capital Inc. Buys New Stake in AptarGroup, Inc. $ATR
Cornerstone Capital Inc. has acquired a new stake in AptarGroup, Inc. (NYSE:ATR) by purchasing 198,775 shares valued at approximately $24.9 million, making it 2.2% of their portfolio. AptarGroup reported strong quarterly results, exceeding EPS and revenue forecasts, and maintaining a "Moderate Buy" consensus rating …
37,700 Shares in Septerna, Inc. $SEPN Purchased by Renaissance Technologies LLC
Renaissance Technologies LLC has acquired a new stake of 37,700 shares in Septerna, Inc. (NASDAQ:SEPN) valued at $906,000. This comes as Septerna reported better-than-expected quarterly results and received positive sentiment from analysts, with a consensus "Moderate Buy" rating and an average price target of …
AirSculpt Technologies (NASDAQ:AIRS) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded AirSculpt Technologies (NASDAQ:AIRS) from a "buy" to a "hold" rating, following the company's recent miss on quarterly earnings and revenue expectations. AirSculpt reported $0.01 EPS against an expected $0.02 and $42.9 million in revenue versus $44.14 million anticipated. Despite …
AIxCrypto Holdings Reports Second Quarter 2026 Results
AIxCrypto Holdings (NASDAQ: AIXC) announced its Q2 2026 financial results, highlighting a strategic shift towards commercializing RoboShare, an on-demand robot sharing marketplace. The company reported a 32% sequential decrease in operating expenses and an unchanged share count, alongside progress in its Los Angeles RoboShare …
Ra Capital Management sells $63.45m in Septerna stock
RA Capital Management, a major shareholder in Septerna Inc. (NASDAQ:SEPN), sold 1,493,000 shares of common stock for a total of $63.45 million on August 12, 2026. The sale occurred after Septerna's stock surged 280% over the past year, with shares trading at $42.50 during …
Driehaus Capital Management (SEPN) discloses 4.43M-share Septerna stake in 13G/A
Driehaus Capital Management LLC has filed an amended Schedule 13G/A, reporting a beneficial ownership of 4,433,058 shares of Septerna, Inc. common stock, which represents 9.83% of the class. Driehaus holds shared voting and dispositive power over these shares, managed across numerous client accounts. The …
Applied Optoelectronics (AAOI) Expected to Announce Business Updates Next Week
Applied Optoelectronics (NASDAQ:AAOI) saw its share price increase by 15.53 percent on Friday to finish at $150.28 apiece, as investors began positioning portfolios in anticipation of major business updates. According to the company, Chief Finance and Strategy Officer Stefan Murry is set to present …
How (OPXS) Movements Inform Risk Allocation Models
The article analyzes Optex Systems Holdings Inc. (NASDAQ: OPXS) using AI models, identifying a near-term weak sentiment that may lead to a resumption of long-term weakness. It highlights an exceptional 51.3:1 risk-reward short setup and outlines three distinct trading strategies (Position, Momentum Breakout, and …
Applied Optoelectronics (AAOI) Could Be 93% Overvalued As Amazon Deal Lifts Revenue Hopes
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Applied Optoelectronics (AAOI) is in focus after a multi-year supply agreement with Amazon, fresh third quarter 2026 revenue guidance, and second quarter earnings …
AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of AdaptHealth Corp. (NASDAQ: AHCO) purchasers following a significant drop in share price. The investigation stems from AdaptHealth's Q2 2026 earnings report, which showed revenue and adjusted EBITDA well below expectations, a GAAP …
Third Rock Ventures V, L.P. director sells $7.4m Septerna shares
Third Rock Ventures V, L.P., a significant shareholder and director of Septerna, Inc., sold 147,200 shares of the company's common stock for approximately $7.4 million on August 12, 2026. The sales were executed through a pre-arranged trading plan, with shares trading near their 52-week …
Top Optimi Health (OPTH) Competitors 2026
This article analyzes Optimi Health (OPTH) against its main competitors in the pharmaceuticals industry: Rafael (RFL), ImmuCell (ICCC), Cognition Therapeutics (CGTX), PolyPid (PYPD), and RF Acquisition Corp II (RFAI). The comparison is based on factors such as profitability, valuation, earnings, analyst recommendations, institutional ownership, …